20940-42-5

Basic information

• Product Name: 3-Chlorobenzylurea
• Synonyms: 1-(3-CHLOROPHENYL)-3-METHYLUREA
• CAS NO: 20940-42-5
• Molecular Formula: C₈H₉ClN₂O
• Molecular Weight: 184.6229
• Mol File: 20940-42-5.mol
• Article Data: 1

Chemical Properties

• Boiling Point: 263.5°Cat760mmHg
• Flash Point: 113.2°C
• Appearance: /
• Density: 1.288g/cm³
• Vapor Pressure: 0.000413mmHg at 25°C
• Refractive Index: 1.579
• CAS DataBase Reference: 3-Chlorobenzylurea(CAS DataBase Reference)
• NIST Chemistry Reference: 3-Chlorobenzylurea(20940-42-5)
• EPA Substance Registry System: 3-Chlorobenzylurea(20940-42-5)

Safety Data

• Hazardous Substances Data: 20940-42-5(Hazardous Substances Data)

Usage

InChI:InChI=1/C8H9ClN2O/c9-7-3-1-2-6(4-7)5-11-8(10)12/h1-4H,5H2,(H3,10,11,12)

Upstream product

• 624-83-9 methyl isocyanate 
• 108-42-9 3-chloro-aniline 
• 372-09-8 cyanoacetic acid 
• 2909-38-8 m-chlorophenyl isocyanate 

Downstream Products

• 36744-16-8 3-(3-chloro-phenyl)-5-methyl-[1,3,5]thiadiazinan-4-one 
• 21562-02-7 N-<3-Chlor-phenyl>-N'-methyl-N'-nitroso-harnstoff 
• 38655-58-2 3-(3-chloro-phenyl)-5-hydroxy-1-methyl-imidazolidine-2,4-dione 
• 34065-97-9 1-(3-chloro-phenyl)-5-hydroxy-3-methyl-imidazolidine-2,4-dione 
• 176379-67-2 6-amino-1-(3-chloro-phenyl)-3-methyl-1H-pyrimidine-2,4-dione 
• 176379-68-3 5,6-diamino-1-(3-chlorophenyl)-3-methyl-2,4 (1H, 3H)-pyrimidinedione 
• 36743-36-9 3-(3-chloro-phenyl)-5-methyl-1,1-dioxo-1λ⁶-[1,3,5]thiadiazinan-4-one 

Relevant articles and documents

1-arylpyrimidine derivatives and pharmaceutical use thereof

The present invention relates to 1-arylpyrimidine derivatives represented by general formula (I): STR1 wherein R1 is H, alkyl or aralkyl; Ar is 1-naphthyl, or a substituted or unsubstituted phenyl group; R4 is a substituted phenyl, a substituted styryl, 1-methylcyclohexyl, 4-methylcyclohexyl, 4-oxo-4H-pyran-2-yl or 2-oxo-2H-pyran-5-yl group; R5 and R6 are each independently H or alkyl; R3 is H, and R7 and R8 are combined together to be oxo, or else R3 and R7 are combined together to be another direct bond, and R5 and R8 are combined together to be a direct bond, or pharmaceutically acceptable salts thereof; and methods for treating allergic diseases with such compounds.